The support of R&D projects by experts and specialized firms can be essential in the development of a drug. This enables informed choices to be made more quickly, which is necessary for emergency situations such as those generated by the COVID-19 epidemic.
This service is designed for Biotech companies developing SARS-CoV-2 new drugs.
Materials to provide
Details about the project.
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
Typical deliverables
Consulting service as validated with the Expert.
Get started with your COVID-19 drug development consulting request
Please answer the fields below to be contacted by our team of scientists
